PofoliaShared via Pofolia

Nature Communications· 2017Q1

High grade serous ovarian carcinomas originate in the fallopian tube

Sana Intidhar Labidi‐Galy, Eniko Papp, Dorothy Hallberg, Noushin Niknafs et al.

Short summary

High-grade serous ovarian carcinomas (HGSOC) originate in the fallopian tube, with p53 signatures and serous tubal intraepithelial carcinomas (STICs) identified as precursors.

AI-generated from the title and abstract; the full text is not read.

Key points

  • High-grade serous ovarian carcinomas (HGSOC) originate in the fallopian tube.
  • p53 signatures and serous tubal intraepithelial carcinomas (STICs) are precursors to HGSOC.
  • The majority of tumor-specific genetic alterations in HGSOC were found in STICs.
  • A 7-year period exists between STIC development and the onset of ovarian carcinoma.

AI-generated from the title and abstract; the full text is not read.

Abstract

High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian cancer and has a poor outcome. It has been proposed that fallopian tube cancers may be precursors of HGSOC but evolutionary evidence for this hypothesis has been limited. Here, we perform whole-exome sequence and copy number analyses of laser capture microdissected fallopian tube lesions (p53 signatures, serous tubal intraepithelial carcinomas (STICs), and fallopian tube carcinomas), ovarian cancers, and metastases from nine patients. The majority of tumor-specific alterations in ovarian cancers were present in STICs, including those affecting TP53, BRCA1, BRCA2 or PTEN. Evolutionary analyses reveal that p53 signatures and STICs are precursors of ovarian carcinoma and identify a window of 7 years between development of a STIC and initiation of ovarian carcinoma, with metastases following rapidly thereafter. Our results provide insights into the etiology of ovarian cancer and have implications for prevention, early detection and therapeutic intervention of this disease.

The authors' abstract, as published at the source. Nature Communications, 2017 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Reproductive Medicine

Reproductive MedicineMedicine